Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,619
in 1 filing, $6K under 10b5-1 plans

Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$6K Director sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2022-05-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −5,300 66,105
2022-04-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion +5,300 $0.30 $2K 91,000
2022-04-11 Lachey Jennifer Chief Scientific Officer Sale −1,417 $61.37 $87K 89,583
2022-04-11 Lachey Jennifer Chief Scientific Officer Sale −1,009 $62.32 $63K 88,574
2022-04-11 Lachey Jennifer Chief Scientific Officer Sale −2,315 $63.50 $147K 86,259
2022-04-11 Lachey Jennifer Chief Scientific Officer Sale −559 $64.15 $36K 85,700
2022-04-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −5,300 71,405
2022-04-06 Rovaldi Christopher Chief Operating Officer Exercise or conversion +1,728 $16.00 $28K 1,728
2022-04-06 Rovaldi Christopher Chief Operating Officer Sale −1,728 $65.00 $112K 0
2022-04-06 Rovaldi Christopher Chief Operating Officer Exercise or conversion · Employee Stock Option (right to buy) −1,728 8,002
2022-04-04 Lachey Jennifer Chief Scientific Officer Exercise or conversion +7,950 $0.30 $2K 93,650
2022-04-04 Lachey Jennifer Chief Scientific Officer Sale −7,950 $60.00 $477K 85,700
2022-04-04 Lachey Jennifer Chief Scientific Officer Exercise or conversion · of Shares Employee Stock Option (right to buy) −7,950 76,705
2022-04-01 Rovaldi Christopher Chief Operating Officer Exercise or conversion +864 $16.00 $14K 864
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −2 $54.34 $109 862
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −104 $56.20 $6K 758
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −287 $56.89 $16K 471
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −366 $57.97 $21K 105
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −105 $58.83 $6K 0
2022-04-01 Rovaldi Christopher Chief Operating Officer Exercise or conversion · Employee Stock Option (right to buy) −864 9,730

Page 10 of 36 · 707 trades